Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

Clinical trial NCT05481879 · RECRUITING

Trial details

NCT number: NCT05481879
Sponsor: Dyne Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myotonic Dystrophy Type 1 (DM1)

Start date: 2022-09-05
Primary completion: 2029-07-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.